Related Experiment Video
Updated: Apr 24, 2026

03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.8K
SNOT-22 validation in greek patients
Fokion Seferlis1, Efklidis Proimos, Theognosia S Chimona
1ENT Department, Chania General Hospital, Chania, Greece.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
|September 9, 2014
Summary
The Greek version of the Sinonasal Outcome Test (SNOT-22) is a valid and reliable tool for assessing chronic rhinosinusitis symptoms in Greek patients. This validated questionnaire improves quality of life evaluations for Greek clinicians.
Area of Science:
- Otolaryngology
- Health Outcomes Research
Background:
- Chronic rhinosinusitis (CRS) is a prevalent condition impacting patient health.
- The Sinonasal Outcome Test (SNOT-22) is a key health status instrument for CRS.
- A Greek translation of SNOT-22 is crucial for local patient assessment and quality of life evaluation.
Purpose of the Study:
- To validate the Greek translation of the SNOT-22 questionnaire.
- To assess the reliability and validity of the Greek SNOT-22 in patients with CRS.
Main Methods:
- A study involving 40 patients with CRS without nasal polyps and 40 healthy controls.
- Comprehensive ENT examinations and nasal endoscopy were performed.
- Test-retest reliability, internal consistency (Cronbach's alpha), and validity were evaluated by comparing patient and control group results.
Main Results:
- The Greek SNOT-22 demonstrated high internal consistency (Cronbach's alpha: 0.934 test, 0.856 retest).
- Excellent test-retest reliability was observed (average kappa value: 0.94).
- Statistically significant differences (p < 0.05) were found between patient and control groups.
Conclusions:
- The study confirms a valid and reproducible Greek version of the SNOT-22.
- This Greek SNOT-22 facilitates symptom assessment and quality of life evaluation for Greek-speaking patients.
- The questionnaire is highly recommended for Greek clinicians managing CRS.

